In addition, the fact that participants with Type 2 diabetes and polycystic ovary syndrome had lower circulating hepcidin levels than control subjects suggests that inflammation is not the predominant factor regulating hepcidin levels in these individuals. This evidence concerns the gene HAMP and polycystic ovary syndrome.